Treatment

DS9051b clinical trials

1 indexed studies · 1 currently recruiting

RecruitingPHASE1
A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer
This study is testing a new drug, DS9051b, for people with advanced adrenal gland cancer or prostate cancer that has spread. Researchers want to see if it's safe, how much to give, and if it shows early signs of working.
For: Advanced or Metastatic Adrenocortical Carcinoma · Metastatic Castration-resistant Prostate Cancer
United States · France · United Kingdom